Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.9772
-0.0217 (-2.17%)
May 13, 2025, 12:49 PM - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $8.22 million as of May 13, 2025. Its market cap has decreased by -87.13% in one year.
Market Cap
8.22M
Enterprise Value
11.52M
1-Year Change
-87.13%
Ranking
Category
Stock Price
0.98
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $8.22M, a decrease of -94.46%. That is a compound annual growth rate of -50.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 8.41M | 160.86% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |